The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3677-3683

  Chen, Ling Chun ^a,e   Manjeshwar, Sharmila ^a   Lu, You ^a,f   Moore, Dan ^a   Ljung, Britt Marie ^b   Kuo, Wen Lin ^c   Dairkee, Shanaz H ^a   Wernick, Meredith ^d   Collins, Colin ^d   Smith, Helene S ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e Geraldine Brush Cancer Res Inst   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ARTICLE; BREAST CANCER; CAENORHABDITIS ELEGANS; CARCINOGENESIS; CELL CYCLE; CHROMOSOME MAP; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CAENORHABDITIS ELEGANS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; CULLIN PROTEINS; FEMALE; GENE AMPLIFICATION; HELMINTH PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS;

EID: 0032529631     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Stark, G. R., Debatisse, M., Giulotto, E., and Wahl, G. M. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell, 57: 901-908, 1989.
2. Gebhart, E., Bruderlein, S., Augustus, M., Siebert, E., Feldner, J., and Schmidt, W. Cytogenetic studies on human breast carcinomas. Breast Cancer Res. Treatment, 8: 125-138, 1986.
3. Saint-Ruf, C., Gerbault-Seureau, M., Viegas-Pequignot, E., Zafrani, B., Cassingena, R., and Dutrillaux, B. Proto-oncogene amplification and homogeneously staining regions in human breast carcinomas. Genes Chromosomes Cancer, 2: 18-26, 1990.
4. Zafrani, B., Gerbault-Seureau, M., Mosseri, V., and Dutrillaux, B. Cytogenetic study of breast cancer: clinicopathological significance of homogeneously staining regions in 84 patients. Hum. Pathol., 23: 542-547, 1992.
5. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
6. Machotka, S. V., Garret, C. T., Schwartz, A. M., and Callahan, R. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer. Clin. Chim. Acta, 4: 207-218, 1989.
7. Lammie, G. A., and Peters, G. Chromosome 11q13 abnormalities in human cancer. Cancer Cells. 3: 413-420, 1991.
8. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
9. Adnane, J., Gaudray, P., Dionne, C. A., Crumley, G., Jaye, M., Schlessinger, J., Jeanteur, P., Birnbaum, D., and Theillet, C. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene, 6: 659-663, 1991.
10. Kallioniemi, A., Kallioniemi, O-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
11. Kallioniemi, A., Kallioniemi, O-P., Piper, J., Chen, L-C., Smith, H. S., Gray, J. W, Pinkel, D., and Waldman. F. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA, 91: 2156-2160, 1994.
12. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-970, 1992.
13. Liang, P., Averboukh, L., Khandan, K., Sager, R., and Pardee, A. B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res., 52: 6966-6968, 1992.
14. Liang, P., Averboukh, L., and Pardee, A. B. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res., 21: 3269-3275, 1993.
15. Kipreos, E. T., Lander, L. E., Wing, J. P., He, W. W., and Hedgecock, E. M. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell, 85: 828-839, 1996.
16. Smith, H. S., Wolman, S. R., Dairkee, S. H., Hancock, M. C., Lippman, M., Leff, A., and Hackett, A. J. Immortalization in culture: occurrence at a late stage in the progression of breast cancer. J. Natl. Cancer Inst. (Bethesda), 78: 611-615, 1987.
17. Smith, H. S., Lan, S., Ceriani, R., Hackett, A. J., and Stampfer, M. R. Clonal proliferation of cultured nonmalignant and malignant breast epithelia. Cancer Res., 41: 4637-4643, 1981.
18. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual, pp. 16-19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
19. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503-517, 1975.
20. McIntyre, P., and Stark, G. R. A quantitative method for analyzing specific DNA sequences directly from whole cells. Anal. Biochem., 174: 209-214, 1988.
21. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 7.23-7.25. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
22. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 7.43-7.48. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
23. Stokke, T., Collins C., Kuo, W-L., Kowbel, D., Shadravan, F., Tanner, M., Kallioniemi, O-P., Pinkel, D., Deaven, L., and Gray, J. W. A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. Genomics, 26: 134-137, 1995.
24. Owen, D. B. Noncentral t and tolerance limits. In: Z. W. Birnbaum (ed.), Handbook of Statistical Tables, pp. 108-127. Reading, MA: Addison-Wesley, 1962.
25. Angerer, L. M., and Angerer, R. C. In situ hybridization to cellular RNA. In: D. Rickwood and B. D. Hames (eds.), In Situ Hybridization, pp. 15-32. London: LRL Press, 1992.
26. Panoskaltsis-Mortari, A., and Bucy, R. P. In situ hybridization with digoxigeninlabeled RNA probes: facts and artifacts. BioTechniques, 18: 300-307, 1995.
27. Dairkee, S. H., and Smith, H. S. Genetic analysis of breast cancer progression. J. Mamm. Gland Biol. Neoplasia, 1: 139-151, 1996.
28. Burnatowska-Hledin, M. A., Spielman, W. S., Smith, W. L., Shi, P., Meyer, J. M., and Dewitt, D. L. Expression cloning of an AVP-activated, calcium-mobilization receptor from rabbit kidney medulla. Am. J. Physiol., 268: F1198-F1210, 1995.
29. Byrd, P. J., Stankovic, T. McConville, C. M., Smith, A. D., Cooper, P. R., and Taylor, A. M. R. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Res., 7: 71-75, 1997.
30. Jackson, P. A. Cell cycle: cull and destroy. Curr. Biol., 6: 1209-1212, 1996.
31. Willems, A. R., Lanker, S., Patton, E. E., Craig, K. L., Nason, T. F., Mathias, N., Kobayashi, R., Wittenberg, C., and Tyers, M. Cdc53 targets phosphorylated GI cyclins for degradation by the ubiquitin proteolytic pathway. Cell, 86: 453-463, 1996.
32. Pause, A., Lee, S., Worrell, R. A., Chen, D. Y., Burgess, W. H., Linehan, W. M., and Klausner, R. D. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human cul-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. USA, 94: 2156-2161, 1997.